Literature DB >> 22298971

Strategies for management of Clostridium difficile infection in immunosuppressed patients.

David G Binion1.   

Abstract

Entities:  

Year:  2011        PMID： 22298971      PMCID： PMC3264928     

Source DB:  PubMed          Journal:  Gastroenterol Hepatol (N Y)        ISSN： 1554-7914


× No keyword cloud information.
  5 in total

1.  Prevalence and clinical impact of endoscopic pseudomembranes in patients with inflammatory bowel disease and Clostridium difficile infection.

Authors:  Shomron Ben-Horin; Maya Margalit; Peter Bossuyt; Jochen Maul; Yami Shapira; Daniela Bojic; Irit Chermesh; Ahmad Al-Rifai; Alain Schoepfer; Matteo Bosani; Matthieu Allez; Peter Laszlo Lakatos; Fabrizio Bossa; Alexander Eser; Tommaso Stefanelli; Franck Carbonnel; Konstantinos Katsanos; Davide Checchin; Inés Sáenz de Miera; Walter Reinisch; Yehuda Chowers; Gordon William Moran
Journal:  J Crohns Colitis       Date:  2009-11-22       Impact factor: 9.071

Review 2.  Fidaxomicin: a macrocyclic antibiotic for the treatment of Clostridium difficile infection.

Authors:  Jennifer S Hardesty; Paul Juang
Journal:  Pharmacotherapy       Date:  2011-09       Impact factor: 4.705

Review 3.  Impact of Clostridium difficile on inflammatory bowel disease.

Authors:  Ashwin N Ananthakrishnan; David G Binion
Journal:  Expert Rev Gastroenterol Hepatol       Date:  2010-10       Impact factor: 3.869

4.  Temporal trends in disease outcomes related to Clostridium difficile infection in patients with inflammatory bowel disease.

Authors:  Ashwin N Ananthakrishnan; Emily L McGinley; Kia Saeian; David G Binion
Journal:  Inflamm Bowel Dis       Date:  2010-09-07       Impact factor: 5.325

5.  Clostridium difficile Infection and Inflammatory Bowel Disease: A Review.

Authors:  Preetika Sinh; Terrence A Barrett; Laura Yun
Journal:  Gastroenterol Res Pract       Date:  2011-09-12       Impact factor: 2.260
  5 in total
  2 in total

Review 1.  Preventing infective complications in inflammatory bowel disease.

Authors:  Justine Mill; Ian C Lawrance
Journal:  World J Gastroenterol       Date:  2014-08-07       Impact factor: 5.742

2.  Toxigenic Clostridium difficile isolates from clinically significant diarrhoea in patients from a tertiary care centre.

Authors:  Meenakshi Singh; Chetana Vaishnavi; Rakesh Kochhar; Safrun Mahmood
Journal:  Indian J Med Res       Date:  2017-06       Impact factor: 2.375
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.